![](/wp-content/uploads/2020/05/Novo-Teva-Xeris-BD-Earnings-2.png)
$599
Novo Q1 ’20 Earnings Roadshow; Xeris, Teva, and BD Earnings Updates
Novo Nordisk hosted its post-Q1 ’20 earnings roadshow event. Additionally, Xeris, Teva, and Becton Dickinson held their respective Q1 ’20 earnings calls. Teva did not discuss its generic liraglutide nor did BD discuss the status of its T2DM patch pump. Below, FENIX provides highlights and insights from the respective earnings calls.